Schubert & CO Alnylam Pharmaceuticals, Inc. Transaction History

Schubert & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$182.66 - $235.53 $547 - $706	-3 Reduced 37.5%	5 $1,000
Q4 2022 Jan 31, 2023	BUY	$185.53 - $241.31 $556 - $723	3 Added 60.0%	8 $1,000
Q2 2022 Aug 01, 2022	BUY	$120.42 - $169.29 $120 - $169	1 Added 25.0%	5 $1,000
Q1 2022 May 16, 2022	SELL	$127.18 - $173.91 $127 - $173	-1 Reduced 20.0%	4 $1,000
Q4 2021 Jan 28, 2022	BUY	$159.56 - $209.29 $797 - $1,046	5 New	5 $1,000

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Schubert & CO, based on Form 13F filings with the SEC.

Stay updated on Schubert & CO with notifications on news.